1. Home
  2. QXL vs VRCA Comparison

QXL vs VRCA Comparison

Compare QXL & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum X Labs Inc. Common Stock

QXL

Quantum X Labs Inc. Common Stock

N/A

Current Price

$3.83

Market Cap

80.9M

Sector

Technology

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$3.51

Market Cap

88.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QXL
VRCA
Founded
N/A
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.9M
88.0M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
QXL
VRCA
Price
$3.83
$3.51
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $13.83
AVG Volume (30 Days)
28.1K
★ 48.5K
Earning Date
08-18-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.10
N/A
Revenue
$26,941,000.00
★ $35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$60.79
P/E Ratio
$38.10
★ N/A
Revenue Growth
N/A
★ 370.22
52 Week Low
$3.51
$3.28
52 Week High
$7.70
$9.82

Technical Indicators

Market Signals
Indicator
QXL
VRCA
Relative Strength Index (RSI) 45.35 35.26
Support Level N/A $3.30
Resistance Level $4.97 $5.94
Average True Range (ATR) 0.38 0.34
MACD 0.01 0.00
Stochastic Oscillator 35.32 10.19

Price Performance

Historical Comparison
QXL
VRCA

About QXL Quantum X Labs Inc. Common Stock

Quantum X Labs Inc is an Israel-based multi-disciplinary quantum technology company focused on the research, development, and commercialization of quantum technologies and intellectual property. The company operates across a broad range of domains, including quantum computing, quantum sensing, navigation systems, atomic clocks, and quantum algorithms, with applications spanning defense, aerospace, transportation, cybersecurity, and life sciences.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: